Development of a New Method for Liver Stiffness Measurement Using FibroScan

NARecruitingINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

November 8, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

May 31, 2027

Conditions
Liver Diseases
Interventions
DEVICE

Research FibroScan (FS)

"Patients #1 to #25:~Exam 1: Examination with Research FibroScan. Exam 2: Examination with the Reference FibroScan at the same measurement point and with the same probe used for the Exam 1.~Patients #26 to #75:~Exam 1: Examination with the Research or Reference FibroScan. Exam 2: Examination with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exam 1.~Patients #76 to #114:~Exams 1 \& 2: 2 consecutive examinations with the Research or Reference FibroScan.~Exams 3 \& 4: 2 consecutive examinations with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exams 1 \& 2."

Trial Locations (2)

75013

RECRUITING

Hôpital Pitié-Salpêtrière, Paris

91400

RECRUITING

Groupe Hospitalier Nord Essonne - Site Paris- Saclay, Orsay

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Echosens

INDUSTRY

NCT06519331 - Development of a New Method for Liver Stiffness Measurement Using FibroScan | Biotech Hunter | Biotech Hunter